Trusted by 100,000+ International Patients
HIPEC: India vs Malaysia
Cost, Quality & Recovery Compared
$11000
India Starting Cost
$83680
Malaysia Starting Cost
See how these top medical tourism destinations compare for HIPEC.
| Comparison Factor | India | Malaysia | Winner |
|---|---|---|---|
| Average Cost (in USD) | 11000 - 15000 | 83680 - 44478 | India |
| Success Rate (Min and Max) | 55% – 80% | 55% – 80% | Both Equal |
| Advanced Technology | High-volume oncology centres perform CRS + HIPEC with dedicated perfusion systems, PET-CT imaging, and specialised oncology ICUs. | Advanced CRS + HIPEC programs in specialised oncology centres with modern perfusion systems, PET-CT imaging, and minimally invasive/robotic-assisted surgical support | Both Equal |
| JCI Accredited Hospitals | 40+ | 10+ | India |
| Visa Process | Medical Visa (3–7 working days; extendable) | Medical Visa / eVisa / eNTRI (2–5 working days) | Both Equal |
*Costs are estimates and may vary based on hospital, complexity, and package inclusions. See detailed cost breakdown below
Understand exactly where your money goes. Both countries offer all-inclusive packages, but here's how the costs typically break down.
Best for Budget-Conscious Patients
Offered Package Price (Additional Cost Excluded)
Top Hospitals: BLK-Max Super Speciality Hospital , Shanti Mukand Hospital , Aster CMI Hospital , Fortis Hospital
Best for Flexible Donor Requirements
Offered Package Price (Additional Cost Excluded)
Want a personalized cost estimate based on your specific condition?
Get Your Free QuoteBoth India and Malaysia maintain world-class healthcare standards with internationally accredited hospitals and highly trained medical professionals.
JCI-accredited hospitals and NABH-linked quality systems in major oncology centres.
Outcomes depend on patient selection (PCI/CC score) and ICU support; leading centres follow internationally aligned HIPEC protocols.
Regulated under national medical governance, oncology drug handling and surgical safety follow accredited hospital protocols.
Many hospitals in Malaysia are accredited by JCI and MSQH with specialised oncology and surgical units.
HIPEC outcomes depend on cancer type, stage, and completeness of cytoreduction; Malaysian centres follow international oncology protocols and multidisciplinary tumour board approaches.
Healthcare is regulated by the Ministry of Health Malaysia (MOH) and Malaysian Society for Quality in Health (MSQH), ensuring strict standards for oncology care and surgical safety.
| Quality Metric | India | Malaysia |
|---|---|---|
Accredited Hospitals | 40+ | 10+ |
CRS + HIPEC Availability | Yes | Yes |
ICU Support Level | Advanced (tertiary) | Advanced (tertiary ICUs) |
Top Speciality Hospital Hubs | Delhi, Mumbai, Chennai | Kuala Lumpur, Penang |
Both countries have highly qualified and experienced medical specialists trained at premier institutions worldwide. Here's what sets them apart.
Surgical oncologists
Program volumes concentrated in select centres; experience varies by hospital.
Highly specialised surgical oncologists
Moderate to high volume
All surgeons listed on Medigence are verified for their medical license, board certifications, hospital affiliations, and patient outcomes. We conduct background checks and regularly update our database to ensure you're connected with the best medical professionals.
Beyond medical excellence, your comfort during treatment matters. Compare the patient experience at top hospitals in both destinations.
World-class hospitals, exceptional value
Leading tertiary cancer hospitals in India are equipped with advanced operating theatres, HIPEC perfusion machines for heated chemotherapy delivery, surgical oncology ICUs, and comprehensive cancer care facilities, including pathology, imaging, and oncology pharmacy support.
Luxury healthcare experience
Leading hospitals in Malaysia feature advanced operating theatres, specialised HIPEC perfusion systems, surgical oncology ICUs, and integrated cancer care services including molecular diagnostics, pathology, and advanced imaging technologies.
Plan your medical journey with confidence. Here's everything you need to know about travel, visas, and accommodation in both countries.
We provide end-to-end travel assistance including visa facilitation, airport pickups, hotel bookings near your hospital, and local support throughout your stay. Our patient coordinators handle all logistics so you can focus on recovery.
Understanding the recovery process helps you plan better. Here's what to expect after HIPEC in both countries.
HIPEC is performed during cytoreductive surgery, where heated chemotherapy is circulated inside the abdominal cavity.
Patients require close ICU monitoring immediately after surgery.
Local stay is recommended after discharge for wound care and early recovery monitoring.
Gradual recovery occurs with nutritional support, physiotherapy, and oncology follow-ups.
In-person follow-ups recommended at 3, 6, 12 months. Telemedicine available.
HIPEC is performed along with cytoreductive surgery to remove visible tumours and treat microscopic disease.
Patients require ICU monitoring immediately after surgery.
International patients are advised to stay locally for recovery and follow-up.
Recovery improves gradually with nutrition, physiotherapy, and oncology care.
Comprehensive telemedicine follow-up program. Return visits at 6, 12 months if possible.
HIPEC recipients require lifelong immunosuppressant medications. Ensure you have a plan for obtaining these medications and regular blood monitoring in your home country before traveling abroad for surgery.
Every medical procedure carries risks. We believe in complete transparency so you can make a fully informed decision about your HIPEC journey.
Higher-than-average surgical risk due to extensive cytoreduction; ICU and infection pathways are critical.
Expected due to major abdominal surgery; managed with protocols.
Possible due to nutritional depletion; requires nutrition optimisation.
Risk of bowel complications, anastomotic leak, and sepsis; it depends on the extent of surgery.
Chemo agent exposure can affect the kidneys and marrow; supportive monitoring is required.
The right choice depends on your specific situation. Here's a clear guide to help you decide which destination aligns with your needs.
Patients diagnosed with peritoneal surface malignancies, such as colorectal cancer spread to the peritoneum, ovarian cancer, appendix cancer, or pseudomyxoma peritonei, who may benefit from cytoreductive surgery combined with heated intraperitoneal chemotherapy.
Patients with peritoneal malignancies such as colorectal cancer with peritoneal spread, ovarian cancer, appendix tumours, peritoneal mesothelioma, or pseudomyxoma peritonei are suitable for cytoreductive surgery with HIPEC.
Our medical tourism experts can analyze your case and recommend the best destination based on your medical history and budget.
Follow this step-by-step framework to make the right choice for your HIPEC journey.
Doctors confirm diagnosis and evaluate peritoneal disease using the PCI score.
Surgeons assess the feasibility of complete cytoreduction before HIPEC.
Plan ICU recovery, hospital stay, and post-operative care.
Budget for surgery, ICU stay, medicines, and possible complications.
Schedule follow-up monitoring and additional therapy if required.
Let our medical tourism experts guide you through the process. We'll help you:
No obligation • Free consultation • Response within 24 hours
Surgical Oncologist
15 Years of Experience
Dr. Prateek Varshney is a renowned Surgical Oncologist. He has experience of more than 15+ years in surgical Oncology. He is currently practicing as a consultant at Metro Mass Hospital and Cancer Institute. He was also previously associated as a consultant with Sir Ganga Ram Hospital and as a professor at Gujarat Cancer Research Institute. View More
